Register by January 24 to save up to $1200
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Punit Seth, PhDSVP, Research at Alnylam PharmaceuticalsSpeaker
Profile
Prior to his current position at Alnylam, Dr. Punit Seth headed medicinal chemistry and targeted delivery at Ionis Pharmaceuticals. He is co-inventor of Ionis’ Gen 2.5, next-generation chemistry, and LICA (ligand conjugated antisense oligonucleotides) platforms which enhance potency, safety and duration of ASO drugs. Dr. Seth pioneered the use of cyclic peptide ligands targeting the Transferrin receptor 1 to enhance potency of RNA therapeutics in skeletal muscle and heart tissues. He is listed as co-author/co-inventor on over 220 peer-reviewed publications, issued patents and patent applications. Dr. Seth has a Ph.D in organic chemistry from The Ohio State University.
Agenda Sessions
Chairman’s Remarks: Oligonucleotide Discovery to Clinic Case Studies
, 1:55pmView SessionDelivering the Promise of RNAi to Extra-hepatic Tissues
, 3:00pmView Session